Professor Ron Grunstein
|
Professor
C39 - Royal Prince Alfred Hospital |
|
On this page
Themes | Biographical details | Research interests | Teaching areas | Grants | PhD & Masters' project opportunities | Honours project opportunities | Keywords | International links
Themes
Neurosciences and Mental Health; Obesity, Diabetes and Cardiovascular Disease; Healthy Ageing
Biographical details
Ron Grunstein is currently Professor of Sleep Medicine and head of the NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) and the NHMRC Australasian Sleep Trials Network. He has been a Practitioner Fellow of the NHMRC since 2002. Professor Grunstein is a staff specialist physician in Respiratory and Sleep Medicine at Royal Prince Alfred Hospital, has a honorary appointment in respiratory and sleep medicine at St Vincent’s Hospital, Sydney and heads the Sleep and Circadian Research Group, Woolcock Institute of Medical Research. Prof. Grunstein has a strong interest in translational clinical research in sleep health and was involved in the early development of nasal CPAP and non-invasive ventilatory support for sleep-breathing disorders. His current main interests involve in metabolic and neurobiological effects of sleep loss. As well he leads research in the simplification of sleep apnea diagnosis and new treatment interventions in sleep disorders. Dr Grunstein has been a visiting scientist at the University of Gothenburg, Sweden and other overseas universities. He was awarded the Nathaniel Kleitman Award of the American Academy of Sleep Medicine in 2011 and the Distinguished Achievement Award of the Australasian Sleep Association in 2010. in 2012, he was awarded the RPA Foundation research medal. He has a long standing interest in health communication through the media and in 2008 was appointed a Public Member of the Australian Press Council. Dr Grunstein also serves as chief medical advisor to Sleep Disorders Australia, an advocacy body for patients with sleep disorders. He has also advised Australian, British and EU road regulatory bodies on sleep disorders and has served as Associate Editor of Sleep and a member of the editorial board of the Journal of Sleep Research, Sleep Medicine Reviews, Sleep Medicine and Respiratory Research. He has Bachelor of Medicine and Surgery degrees and a Doctor of Medicine from the University of Sydney and a PhD from the University of Gothenburg, Sweden. Professor Grunstein was the President of the World Federation of Sleep Research and Sleep Medicine Societies (2007-11) that represents over 12,000 researchers and sleep clinicians globally and was President of the Australasian Sleep Association 1994-1997.
Research interests
Professor Grunstein has diverse interests in clinical research in sleep disorders and sleep health.Research includes diagnosis, effects and management of sleep apnea, epidemiology of sleep disorders, impact of sleep loss on human health, interaction of work and sleep and evaluating and developing new treatment approaches in sleep disorders.
Teaching areas
Novel methods of teaching and training in sleep medicine
Current national competitive grants*
2012
Novel brain biomarkers of neurobehavioural dysfunction in obstructive sleep apnea
Grunstein R, Rae C, Wong K, McEvoy R
NHMRC Project Grants ($403,072 over 3 years)
Practitioner Fellowship 2
Grunstein R
NHMRC Career Awards: Practitioner Fellowships ($523,725 over 5 years)
2011
Modafinil for neurobehavioural dysfunction in sleep apnea patients who cannot use standard device-based treatments.
Marshall N, Grunstein R, Wong K, Yee B
NHMRC Project Grant ($423,984 over 3 years)
2009
CCRE in Interdisciplinary Sleep Health
Grunstein R, Anderson C, Liu P, Cistulli P, Glozier N, Armour C, Robinson P, Marks G
National Health and Medical Research Council Centre of Clinical Research Excellence ($2,500,000 over 6 years)
* Grants administered through the University of Sydney
PhD and Masters' project opportunities
Developing a psychoeducation program to improve sleep-wake disturbances in Parkinson’s Disease
Chronotherapy for hypertension in obstructive sleep apnea
Creatine therapy to improve neurobehavioural function in obstructive sleep apnea
The effect of modafinil on daytime sleepiness, neurobehavioural performance and quality of life in obstructive sleep apnea patients
Which sleep apnea patients have problems with alertness and attention?
International links
Sweden. (University of Gothenburg) Research collaboration in the Swedish Obese Subjects Cohort a controlled trial of weight loss surgery.
United Kingdom. (University of Surrey) research into sleep homeostasis and circadian neurobiology in sleep disorders.
United States. (Centre for Respiratory Neurobiology, University of Pennsylvania) ongoing collaboration with Professor Allan Pack, in phenotyping and genotyping patients with sleep disorders.
United Kingdom. (University of Glasgow) shared PHD students, NHMRC projects and CCRE behavioural sleep medicine.